Avior, Inc.
Cary, NC, US· latest recorded location
Avior, Inc. is named on 4 US grants and 3 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 4
- Published applications
- 3
- Inventors
- 4
- Granted in 2026 so far
- 1
- Most recent grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 3 |
| 2022 | 2 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 7 documents
Recent patents
- Method and device of treating chronic kidney disease-associated pruritus2 Jun 2026US 12,642,796 B2
- Transmucosal film composition and methods of making and using the same22 Nov 2022US 11,504,342 B2
- Pharmaceutical active-containing film delivery device for oral transmucosal administration3 May 2022US 11,318,107 B2
- Extending secure single sign on to legacy applications25 Aug 2015US 9,118,657 B1
- Method and device of treating chronic kidney disease-associated pruritus2 Dec 2021US 2021/0369703 A1
- Transmucosal film composition and methods of making and using the same25 Mar 2021US 2021/0085622 A1
- Pharmaceutical active-containing film delivery device for oral transmucosal administration4 Feb 2021US 2021/0030693 A1
Most cited
By later US patents